Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects
Clinical trial NCT03681457 · COMPLETED
Trial details
- NCT number
- NCT03681457
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2019-09-25
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.